Patents by Inventor Sung Yeoun HWANG

Sung Yeoun HWANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11285226
    Abstract: The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERR?) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: March 29, 2022
    Assignees: Daegu-Gyeongbuk Medical Innovation Foundation, KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL, Kyungpook National University Industry-Academic Cooperation Foundation
    Inventors: Sung Yeoun Hwang, Sung Jin Cho, Jina Kim, Jungwook Chin, Hayoung Hwang, In-Kyu Lee, Yong-Hyun Jeon, Jaetae Lee, Jae-Han Jeon, Sang Wook Kim
  • Patent number: 10934303
    Abstract: The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERR?) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: March 2, 2021
    Assignees: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION, KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL, KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Sung Yeoun Hwang, Sung Jin Cho, Jina Kim, Jungwook Chin, Hayoung Hwang, In-Kyu Lee, Yong-Hyun Jeon, Jaetae Lee, Jae-Han Jeon, Sang Wook Kim
  • Publication number: 20210046140
    Abstract: A method for preventing or treating overactive bladder includes administering a composition to a subject in need thereof. The composition includes extracts having a Corni Fructus extract, an Angelica gigantis Radix extract, a Lycii Fructus extract, a Cervi parvum cornu extract, a Ginseng Radix Rubra extract, and a Cassiae cortkex extract. The overactive bladder may be a complication of benign prostatic hyperplasia, and the composition may further include an alpha-1A adrenoceptor antagonist. The overactive bladder may be caused by secondary bladder degeneration occurring due to bladder outlet obstruction. The composition may be included in a pharmaceutical composition or a health functional food. The composition also exhibits an excellent effect on overactive bladder that is not relieved even when bladder outlet obstruction disappears by benign prostatic hyperplasia surgical treatment or administration of an alpha-blocker or the like.
    Type: Application
    Filed: March 24, 2017
    Publication date: February 18, 2021
    Inventors: Sung Yeoun HWANG, Sae Woong KIM
  • Publication number: 20200078476
    Abstract: The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERR?) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.
    Type: Application
    Filed: November 7, 2019
    Publication date: March 12, 2020
    Inventors: Sung Yeoun HWANG, Sung Jin CHO, Jina KIM, Jungwook CHIN, Hayoung HWANG, In-Kyu LEE, Yong-Hyun JEON, Jaetae LEE, Jae-Han JEON, Sang Wook KIM
  • Publication number: 20190314436
    Abstract: A composition for prevention or treatment of liver cancer includes a Nardostachys jatamansi extract. The composition exhibits anti-cancer effects on liver cancer and/or specific liver cancer resistant to antibiotics. The composition can be included, for example, in a pharmaceutical composition or a health functional food.
    Type: Application
    Filed: November 4, 2016
    Publication date: October 17, 2019
    Inventors: Sung-Yeoun HWANG, Seung-Kew YOON, Jung-Hee KIM
  • Publication number: 20190167820
    Abstract: The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERR?) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.
    Type: Application
    Filed: September 13, 2016
    Publication date: June 6, 2019
    Inventors: Sung Yeoun HWANG, Sung Jin CHO, Jina KIM, Jungwook CHIN, Hayoung HWANG, In-Kyu LEE, Yong-Hyun JEON, Jaetae LEE, Jae-Han JEON, Sang Wook KIM
  • Publication number: 20190161490
    Abstract: The present invention relates to an aryl ethene derivative, for inhibiting an estrogen-related receptor gamma (ERR?) activity, a prodrug of same, a solvate of same, a stereoisomer of same or pharmaceutically acceptable salts of same, and a pharmaceutical composition containing same as an active ingredient.
    Type: Application
    Filed: September 13, 2016
    Publication date: May 30, 2019
    Inventors: Sung Yeoun HWANG, Sung Jin CHO, Jina KIM, Jungwook CHIN, Hayoung HWANG, In-Kyu LEE, Yong-Hyun JEON, Jaetae LEE, Jae-Han JEON, Sang Wook KIM
  • Publication number: 20180193401
    Abstract: A pharmaceutical composition and a health food composition for preventing, treating and improving obesity, which include an extract complex of bamboo leaves and quince as an active ingredient, are disclosed. Because the extract complex has an excellent anti-obesity effect without causing any side effects, the extract complex can be effectively used in a pharmaceutical composition and health food for preventing, improving and treating obesity. Therefore, a novel therapeutic agent whose effect goes beyond conventional natural anti-obesity drugs and a novel therapy can be provided.
    Type: Application
    Filed: January 12, 2018
    Publication date: July 12, 2018
    Inventor: Sung Yeoun HWANG
  • Publication number: 20170112714
    Abstract: A method for alleviating or treating anaphylaxis is disclosed. By allowing patient suffering from anaphylaxis to hear drumming with a buk (a Korean traditional drum), the method can be useful in replacing medicinal treatment since the method has an excellent therapeutic effect with a level similar to that when a drug is administered even without administering any drugs, by reducing various kinds of inflammatory-related factors such as HIF-1?, VEGF, inflammatory cytokines and ER-? in the brain of patient suffering from anaphylaxis.
    Type: Application
    Filed: October 22, 2015
    Publication date: April 27, 2017
    Inventors: Sung Yeoun HWANG, Hyung Min KIM, Hyun-Ja JEONG
  • Publication number: 20160296722
    Abstract: A method for treating depression is disclosed. By allowing patients suffering from depression to hear jinyangjo-jangdan (a very slow rhythm) of sanjo (a style of traditional Korean music), the method can be useful in replacing medicinal treatment since the method has an excellent therapeutic effect with a level similar to that when a drug is administered even without administering any drugs, by promoting the activities of monoamine compounds such as serotonin and a brain-derived neurotrophic factor (BDNF) in the brains of patients suffering from depression.
    Type: Application
    Filed: April 8, 2015
    Publication date: October 13, 2016
    Inventors: Sung Yeoun HWANG, Hyung Min KIM, Hyun-Ja JEONG